Bis(Hydroxamamide)-Based Bifunctional Chelating Agent for 99mTc Labeling of Polypeptides-Reference-Cited by-同舟云学术

Bis(Hydroxamamide)-Based Bifunctional Chelating Agent for 99mTc Labeling of Polypeptides

Published:1998-12-22 Issue:1 Volume:10 Page:9-17
ISSN:1043-1802
Container-title:Bioconjugate Chemistry
language:en
Short-container-title:Bioconjugate Chem.

Author:

Xu Le-Cun¹,Nakayama Morio¹,Harada Kumiko¹,Kuniyasu Akihiko¹,Nakayama Hitoshi¹,Tomiguchi Seiji¹,Kojima Akihiro¹,Takahashi Mutsumasa¹,Ono Masahiro¹,Arano Yasushi¹,Saji Hideo¹,Yao Zhengsheng¹,Sakahara Harumi¹,Konishi Junji¹,Imagawa Yoshitaka¹

Affiliation:

1. Faculty of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-Honmachi, Kumamoto 862, Japan, Department of Radiology, Kumamoto University School of Medicine, Honjo, Kumamoto 860, Japan, Department of Patho-Functional Bioanalysis, Graduate School of Pharmaceutical Sciences, Department of Nuclear Medicine and Diagnostic Imaging, Graduate School of Medicine, Kyoto University, Yoshida-Shimoadachi-cho, Sakyo-ku, Kyoto 606-01, Japan, and The Chemo-Sero Therapeutic Research Institute, Kyokushi-mura, Kikuchi...

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Pharmaceutical Science,Pharmacology,Biomedical Engineering,Bioengineering,Biotechnology

Link

https://pubs.acs.org/doi/pdf/10.1021/bc980024j

Reference33 articles.

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chemical Reaction Engineering Methodologies for Biomedical Imaging Analysis;Biomedical Engineering Challenges;2018-02-09

2. Novel Bivalent 99mTc-Complex with N-Methyl-Substituted Hydroxamamide as Probe for Imaging of Cerebral Amyloid Angiopathy;PLOS ONE;2016-09-30

3. Biocomplexes in radiochemistry;Physical Sciences Reviews;2016-05-31

4. Development and Evaluation of a Novel 99mTc-Labeled Annexin A5 for Early Detection of Response to Chemotherapy;PLoS ONE;2013-12-04

5. Synthesis of a Covalent Epirubicin-(C3-amide)-Anti-HER2/neu Immunochemotherapeutic Utilizing a UV-Photoactivated Anthracycline Intermediate;Cancer Biotherapy and Radiopharmaceuticals;2012-02